We have our own point of view on the people, technologies, and conversations that will shape the future.
Today, Squint revealed an impressive roster of customers that includes Volvo and Siemens, and announced $6 million in seed and pre-seed funding from Sequoia Arc, Menlo Ventures, and Menlo Labs.
While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can help illuminate the path forward.
We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.
Retail e-commerce is as old as the advent of the web. In the decades that followed, a wave of innovation across supply chain, logistics, advertising, payments, checkout, and storefront tech has vastly improved the consumer e-commerce experience.
OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history. The landmark achievement underscored the strength of generative AI’s pull in consumer markets—surpassing even the breakthroughs of the internet and smartphones.
Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.
Nailing your monetization strategy has become more important than ever in today’s weakened macroeconomic climate, and it’s no longer as simple as charging per seat.
Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.
Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.
Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.
Congratulations to Jeremy Zhang, Ansel Parikh, and the Finch team on raising their Series B! For Menlo, it’s an exciting milestone, marking the third consecutive round we’ve invested in Finch.
At Menlo Ventures, we’ve invested in fintech for a long time and, despite the volatility of the last two years, believe there’s still a lot to be excited about.
Economic downturns force us to get back to basics: The cost of new capital and low valuation multiples—even for top-performing public companies—force startups to make substantial progress per dollar to get a term sheet, much less an up round.
Cancer remains one of the leading causes of death in the U.S. and worldwide.
There’s been a seismic shift in the environment for learning and training on the job.